Tailored management of primary gastrointestinal stromal tumors.


Journal

Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 29 11 2018
revised: 10 02 2019
accepted: 14 02 2019
pubmed: 2 4 2019
medline: 25 3 2020
entrez: 2 4 2019
Statut: ppublish

Résumé

Gastrointestinal stromal tumors (GISTs) are the most common human sarcoma and can form along the entire gastrointestinal tract. Over the last 20 years, considerable advances have been made in our understanding of the biology of GISTs. The advent of tyrosine kinase inhibitors has provided effective medical therapy for the first time. In fact, given that GIST typically is driven by either a KIT or PDGFRA gene mutation, it has become a paradigm of targeted molecular therapy. In addition, diagnostic and surgical techniques have been refined. Here, the critical aspects of primary GISTs and how they are now managed with an integrated approach are summarized. Treatment plans are developed based on specific pathologic and molecular features of the tumor. The authors outline the general principles of therapy and highlight some of the nuances. Particular focus is given to diagnosis, surgical considerations, and the use of preoperative and postoperative tyrosine kinase inhibitors.

Identifiants

pubmed: 30933313
doi: 10.1002/cncr.32067
pmc: PMC6773539
mid: NIHMS1015674
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2164-2171

Subventions

Organisme : NCI NIH HHS
ID : R01 CA102613
Pays : United States

Informations de copyright

© 2019 American Cancer Society.

Références

J Clin Oncol. 2002 Sep 15;20(18):3898-905
pubmed: 12228211
Ann Surg Oncol. 2017 Dec;24(13):3972-3980
pubmed: 29058144
J Surg Oncol. 2009 Jan 1;99(1):42-7
pubmed: 18942073
Science. 2003 Jan 31;299(5607):708-10
pubmed: 12522257
J Clin Oncol. 2014 May 20;32(15):1563-70
pubmed: 24638003
World J Gastrointest Endosc. 2015 Mar 16;7(3):192-205
pubmed: 25789089
Ann Surg. 1992 Jan;215(1):68-77
pubmed: 1731651
J Natl Compr Canc Netw. 2007 Jul;5 Suppl 2:S1-29; quiz S30
pubmed: 17624289
Science. 1998 Jan 23;279(5350):577-80
pubmed: 9438854
Lancet. 2004 Sep 25-Oct 1;364(9440):1127-34
pubmed: 15451219
Eur J Surg Oncol. 2011 Oct;37(10):890-6
pubmed: 21737227
J Clin Oncol. 2016 Jan 20;34(3):244-50
pubmed: 26527782
Int J Cancer. 2003 Oct 10;106(6):887-95
pubmed: 12918066
Ann Surg Oncol. 2015 Oct;22(11):3597-605
pubmed: 25652053
Am J Surg Pathol. 2011 Nov;35(11):1712-21
pubmed: 21997692
J Clin Oncol. 2008 Nov 20;26(33):5352-9
pubmed: 18955458
JAMA Oncol. 2017 May 1;3(5):602-609
pubmed: 28334365
JAMA. 2012 Mar 28;307(12):1265-72
pubmed: 22453568
JAMA Oncol. 2018 Dec 1;4(12):e184060
pubmed: 30383140
Surg Endosc. 2008 Jul;22(7):1729-35
pubmed: 18074180
Lancet. 2006 Oct 14;368(9544):1329-38
pubmed: 17046465
Semin Diagn Pathol. 2006 May;23(2):70-83
pubmed: 17193820
Hum Pathol. 2008 Oct;39(10):1411-9
pubmed: 18774375
Cancer. 2012 Nov 1;118(21):5339-48
pubmed: 22517534
J Clin Oncol. 2015 Dec 20;33(36):4276-83
pubmed: 26573069
BMC Cancer. 2011 Feb 15;11:72
pubmed: 21324142
Ann Surg Oncol. 2013 Sep;20(9):2937-43
pubmed: 23760587
Ann Surg Oncol. 2017 Jan;24(1):202-210
pubmed: 27624583
J Clin Oncol. 2007 May 1;25(13):1753-9
pubmed: 17470865
Cancer. 2005 Feb 15;103(4):821-9
pubmed: 15648083
Clin Cancer Res. 2012 Feb 1;18(3):826-38
pubmed: 22167411
Virchows Arch. 2001 Jan;438(1):1-12
pubmed: 11213830
Med Sci Monit. 2007 Nov;13(11):CR515-522
pubmed: 17968300
Ann Surg Oncol. 2012 Apr;19(4):1074-80
pubmed: 22203182
Am J Pathol. 2004 Jul;165(1):107-13
pubmed: 15215166
Ann Surg Oncol. 2011 Jun;18(6):1599-605
pubmed: 21207158
Ann Surg. 2013 Sep;258(3):422-9
pubmed: 23860199
Lancet Oncol. 2009 Nov;10(11):1045-52
pubmed: 19793678
Am J Surg Pathol. 1983 Sep;7(6):507-19
pubmed: 6625048
JAMA Oncol. 2016 Jul 1;2(7):922-8
pubmed: 27011036
J Am Coll Surg. 2012 Jul;215(1):53-9; discussion 59-60
pubmed: 22726733
Ann Surg. 2000 Jan;231(1):51-8
pubmed: 10636102
Br J Cancer. 2010 Mar 30;102(7):1198-9
pubmed: 20179709
Am J Surg Pathol. 2005 Sep;29(9):1170-6
pubmed: 16096406
Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
pubmed: 17090188
J Clin Oncol. 2008 Nov 20;26(33):5360-7
pubmed: 18955451
Lancet. 2013 Jan 26;381(9863):295-302
pubmed: 23177515
Lancet. 2009 Mar 28;373(9669):1097-104
pubmed: 19303137
Clin Cancer Res. 2005 Jun 1;11(11):4182-90
pubmed: 15930355
Ann Surg Oncol. 2018 Jul;25(7):1961-1969
pubmed: 29752602
J Clin Oncol. 2008 Feb 1;26(4):626-32
pubmed: 18235122
Gastroenterology. 1998 Nov;115(5):1090-5
pubmed: 9797363
J Clin Oncol. 2005 Sep 1;23(25):6190-8
pubmed: 16135486
Br J Surg. 2003 Mar;90(3):332-9
pubmed: 12594669
N Engl J Med. 2001 Apr 5;344(14):1052-6
pubmed: 11287975
Radiographics. 2003 Mar-Apr;23(2):283-304, 456; quiz 532
pubmed: 12640147
Lancet. 2001 Oct 27;358(9291):1421-3
pubmed: 11705489
Am J Pathol. 1998 May;152(5):1259-69
pubmed: 9588894
Ann Ital Chir. 2015 May-Jun;86(3):219-27
pubmed: 26098671
N Engl J Med. 2002 Aug 15;347(7):472-80
pubmed: 12181401

Auteurs

Mark S Etherington (MS)

Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ronald P DeMatteo (RP)

Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH